Aldeyra Therapeutics resubmits NDA for reproxalap for DED signs and symptoms treatment
October 3rd 2024Reproxalap was previously found to be statistically superior to vehicle for the primary endpoint of ocular discomfort (P=0.004) in a Phase 3 randomized, double-masked, vehicle-controlled dry eye chamber clinical trial.
Study reports the majority of MiYOSMART spectacle lens users continue use for as long as 8 years
October 1st 2024By alternating the focus area—or the clear zone of the lens—and defocus area—the honeycomb-shaped segment of the lens—the spectacle lenses achieve clear vision and manage myopia progression.
EyeCon 2024: Taking a multidisciplinary approach to diabetic eye care
Mark Dunbar, OD, FAAO, emphasizes the critical role optometrists play in the collaborative care of diabetic eye disease.
VEW 2024: Dr. Jessilin Quint weighs in on dry eye, uveitis, and contact lenses
Her three presentations, "The Business of Contact Lens," "Blueprint for Success: How to Start a Dry Eye Clinic," and "Unveiling Uveitis" were given at this year's Vision Expo West.
VEW 2024: Bringing the excitement of Vegas to eye care
Marc Bloomenstein, OD, FAAO, gives inside scoop into some of the most exciting education opportunities at Vision Expo West, including the conference's "Case Files" series.
VEW 2024: What to know when starting a speciality contact lens practice
Mile Brujic, OD, FAAO, outlines the essentials to starting a speciality contact lens practice, including speciality competency and accessing resources.
VEW 2024: Survey assesses best practice behaviors to help retain contact lens wearers
September 19th 2024The Contact Lens Institute research found that both new and long-term wearers of contact lenses were positively impacted by their eye care providers allowing adequate chair time during exams, among other factors.
VEW 2024: Debunking myths in order to integrate myopia management into your practice
Brianna Rhue, OD, FAAO, FSLS, shares her passion for myopia management and control at this year's Vision Expo West.